Elicitation of polyclonal cytotoxic T-responses to HER-2 in HLA-A0201 mice by a novel multiepitope peptide vaccine

被引：0
|
作者：
Dakappagari, N [1 ]
Kaumaya, PTP [1 ]
机构：
[1] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Dept Obstet & Gynecol, Columbus, OH 43210 USA
来源：
BIOPOLYMERS | 2003年 / 71卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P484
引用
收藏
页码：407 / 407
页数：1
相关论文
共 50 条
  • [21] Isolation of HER-2/neu (HER2) specific gamma-delta TCR T cell clones from an HLA-A2 ovarian cancer patient immunized with a HER2 peptide-based vaccine.
    Knutson, KL
    Disis, ML
    FASEB JOURNAL, 2000, 14 (06): : A1006 - A1006
  • [22] A novel DNA methyltransferase I-derived peptide eluted from soluble HLA-A*0201 induces peptide-specific, tumor-directed cytotoxic T cells
    Berg, M
    Barnea, E
    Admon, A
    Zavazava, N
    INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (03) : 426 - 432
  • [23] Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells
    Kawashima, I
    Tsai, V
    Southwood, S
    Takesako, K
    Sette, A
    Celis, E
    CANCER RESEARCH, 1999, 59 (02) : 431 - 435
  • [24] Identification of HLA-A*0201-restricted cytotoxic T-cell epitopes of Trypanosoma cruzi TcP2β protein in HLA-transgenic mice and patients
    Garcia, F
    Sepulveda, P
    Liegeard, P
    Gregoire, J
    Hermann, E
    Lemonnier, F
    Langlade-Demoyen, P
    Hontebeyrie, M
    Lone, YC
    MICROBES AND INFECTION, 2003, 5 (05) : 351 - 359
  • [25] IDENTIFICATION OF AN IMMUNODOMINANT PEPTIDE OF HER-2/NEU PROTOONCOGENE RECOGNIZED BY OVARIAN TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTE LINES
    FISK, B
    BLEVINS, TL
    WHARTON, JT
    IOANNIDES, CG
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06): : 2109 - 2117
  • [26] CYTOTOXIC T-CELLS ISOLATED FROM OVARIAN MALIGNANT ASCITES RECOGNIZE A PEPTIDE DERIVED FROM THE HER-2/NEU PROTOONCOGENE
    IOANNIDES, CG
    FISK, B
    FAN, D
    BIDDISON, WE
    WHARTON, JT
    OBRIAN, CA
    CELLULAR IMMUNOLOGY, 1993, 151 (01) : 225 - 234
  • [27] Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design
    Bharadwaj, M
    Sherrit, M
    Khanna, R
    Moss, DJ
    VACCINE, 2001, 19 (27) : 3769 - 3777
  • [28] HER-2/neu peptide induces Th1 responses in association with HLA-DR4 in breast cancer patients.
    Tuttle, TM
    Thompson, WE
    Anderson, BW
    Lee, JE
    Grabstein, KW
    Murray, JL
    Wharton, JT
    Ioannides, CG
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 188 - 188
  • [29] CD8+T cell immune responses induced by DNA vaccine expressing M-tuberculosis polytope peptides in HLA-A*0201 transgenic mice
    Rhee, SH
    Cho, SN
    Song, TS
    Bang, HE
    Cho, S
    FASEB JOURNAL, 2004, 18 (05): : A822 - A822
  • [30] Novel EXO-T vaccine using polyclonal CD4+ T cells armed with HER2-specific exosomes for HER2-positive breast cancer
    Li, Rong
    Chibbar, Rajni
    Xiang, Jim
    ONCOTARGETS AND THERAPY, 2018, 11 : 7089 - 7093
12345